Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nuwellis, Inc (NUWE)  
$0.25 0.03 (13.3%) as of 4:30 Fri 5/24


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 6,530,000
Market Cap: 1.63(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.133 - $3.06
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Nuwellis is a medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow® and the Aquadex SmartFlow™ systems. The Aquadex SmartFlow™ system is indicated for temporary (up to eight hours) or extended (longer than eight hours in patients who require hospitalization) use in adult and pediatric patients weighing 20kg or more whose fluid overload is unresponsive to medical management, including diuretics.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 4,098
Total Buy Value $0 $0 $0 $19,629
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 142
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Oleson Kimberly SVP, Clinical Affairs   •       –      –    2015-04-01 4 D $4.26 $1,189 D/D (279) 4,368     -
   Oleson Kimberly SVP, Clinical Affairs   •       –      –    2015-03-01 4 D $5.75 $1,604 D/D (279) 4,647     -
   Rosa David A Chief Executive Officer   •       •      –    2015-03-01 4 D $5.75 $30,050 D/D (5,226) 145,717     -
   Wade Molly Vice President   •       –      –    2015-03-01 4 D $5.75 $3,490 D/D (607) 15,751     -
   Kridner Debra Exec VP, Regulatory Affairs   •       –      –    2015-03-01 4 D $5.75 $3,203 D/D (557) 28,285     -
   Kridner Debra Exec VP, Regulatory Affairs   •       –      –    2015-02-01 4 D $4.98 $2,774 D/D (557) 28,842     -
   Wade Molly Vice President   •       –      –    2015-02-01 4 D $4.98 $3,023 D/D (607) 16,358     -
   Rosa David A Chief Executive Officer   •       •      –    2015-02-01 4 D $4.98 $26,025 D/D (5,226) 150,943     -
   Oleson Kimberly SVP, Clinical Affairs   •       –      –    2015-02-01 4 D $4.98 $1,389 D/D (279) 4,926     -
   Wade Molly Vice PresidentOfficer   •       –      –    2015-01-05 3 IO $0.00 $0 D/D 0 16,965     -
   Mathiesen Jeffrey S Chief Financial Officer   •       –      –    2015-01-01 4 D $4.24 $4,041 D/D (953) 37,223     -
   Kridner Debra Exec VP, Regulatory Affairs   •       –      –    2015-01-01 4 D $4.24 $2,362 D/D (557) 29,399     -
   Rosa David A Chief Executive Officer   •       •      –    2015-01-01 4 D $4.24 $22,158 D/D (5,226) 156,170     -
   Peters William S CTO & Medical Director   •       –      –    2015-01-01 4 D $4.24 $2,883 D/D (680) 33,309     -
   Oleson Kimberly SVP, Clinical Affairs   •       –      –    2015-01-01 4 D $4.24 $1,183 D/D (279) 5,205     -
   Rosa David A Chief Executive Officer   •       •      –    2014-12-01 4 D $4.52 $23,622 D/D (5,226) 161,396     -
   Mathiesen Jeffrey S Chief Financial Officer   •       –      –    2014-12-01 4 D $4.52 $4,308 D/D (953) 38,176     -
   Peters William S CTO & Medical Director   •       –      –    2014-12-01 4 D $4.52 $3,074 D/D (680) 33,989     -
   Oleson Kimberly SVP, Clinical Affairs   •       –      –    2014-12-01 4 D $4.52 $1,261 D/D (279) 5,484     -
   Kridner Debra Exec VP, Regulatory Affairs   •       –      –    2014-12-01 4 D $4.52 $2,518 D/D (557) 29,956     -
   Peters William S CTO & Medical Director   •       –      –    2014-11-01 4 D $4.85 $3,298 D/D (680) 34,669     -
   Kridner Debra Exec VP, Regulatory Affairs   •       –      –    2014-11-01 4 D $4.85 $2,701 D/D (557) 30,513     -
   Rosa David A Chief Executive Officer   •       •      –    2014-11-01 4 D $4.85 $25,346 D/D (5,226) 166,622     -
   Oleson Kimberly SVP, Clinical Affairs   •       –      –    2014-11-01 4 D $4.85 $1,353 D/D (279) 5,763     -
   Mathiesen Jeffrey S Chief Financial Officer   •       –      –    2014-11-01 4 D $4.85 $4,622 D/D (953) 39,129     -
  142 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us